VBI Vaccines Inc/BC Quarterly Operating Income (Loss) in USD from Q1 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
VBI Vaccines Inc/BC quarterly/annual Operating Income (Loss) history and growth rate from Q1 2016 to Q1 2024.
  • VBI Vaccines Inc/BC Operating Income (Loss) for the quarter ending March 31, 2024 was -$11.8M, a 39.8% increase year-over-year.
  • VBI Vaccines Inc/BC Operating Income (Loss) for the twelve months ending March 31, 2024 was -$72.2M, a 15.5% increase year-over-year.
  • VBI Vaccines Inc/BC annual Operating Income (Loss) for 2023 was -$79.9M, a 2.33% increase from 2022.
  • VBI Vaccines Inc/BC annual Operating Income (Loss) for 2022 was -$81.8M, a 20.3% decline from 2021.
  • VBI Vaccines Inc/BC annual Operating Income (Loss) for 2021 was -$68M, a 56% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$72.2M -$11.8M +$7.76M +39.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$79.9M -$13.4M +$8.08M +37.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 -$88M -$10.1M +$11.5M +53.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$99.5M -$37M -$14.1M -61.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$85.4M -$19.5M -$3.59M -22.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$81.8M -$21.4M -$569K -2.73% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$81.3M -$21.6M -$6.53M -43.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$74.7M -$22.9M -$6.46M -39.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$68.3M -$15.9M -$223K -1.42% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$68M -$20.9M -$6.66M -46.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-13
Q3 2021 -$61.4M -$15M -$3.17M -26.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$58.2M -$16.4M -$8.3M -102% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$49.9M -$15.7M -$6.28M -66.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$43.6M -$14.2M -$4.04M -39.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-07
Q3 2020 -$39.6M -$11.9M +$4.29M +26.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$43.9M -$8.14M +$4.13M +33.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 -$48M -$9.41M +$4.41M +31.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$52.4M -$10.2M +$8.34M +45.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 -$60.7M -$16.1M -$1.6M -11% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 -$59.1M -$12.3M +$3.47M +22% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 -$62.6M -$13.8M -$2.2M -18.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$60.4M -$18.5M -$7.53M -68.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$52.9M -$14.5M -$5.4M -59.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$47.5M -$15.7M -$7.42M -89.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$40.1M -$11.6M -$2.78M -31.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 -$37.3M -$11M -$2.32M -26.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-25
Q3 2017 -$35M -$9.14M -$1.4M -18.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$33.6M -$8.31M -$2.43M -41.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-26
Q1 2017 -$31.1M -$8.85M -$6.28M -245% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q4 2016 -$24.9M -$8.67M Oct 1, 2016 Dec 31, 2016 10-K 2018-02-26
Q3 2016 -$7.74M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$5.88M Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-31
Q1 2016 -$2.56M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.